Mammalian sperm cells are not capable of fertilizing an egg immediately after ejaculation; instead, they must gradually acquire the capacity to fertilize while they travel inside the female reproductive tract. Sperm cells are transported by the muscular activity of the myometrium to the utero-tubal junction (UTJ) before entering the oviduct where they undergo this physiological process, termed capacitation. Since the successful emulation of mammalian sperm capacitation in vitro, which led to the development of in vitro fertilization techniques, sperm capacitation and gamete interaction studies have been mostly carried out under in vitro conditions. Sperm cells are typically incubated in vitro for up to several hours at a concentration of more than 1 million cells per milliliter in the capacitation media inside a 37°C incubator with 5% CO2, mimicking the tubal fluid composed of serum albumin, bicarbonate, and Ca2+. The resultant sperm are functionally and molecularly heterogeneous with respect to acrosome reaction, motility, and phosphorylation. By contrast, in vivo sperm capacitation occurs in a time- and space-dependent manner, with limits on the number of capacitating sperm in the oviduct. The small number of sperm at the fertilization site in vivo are highly homogeneous and uniformly capable of fertilization. This discrepancy makes the degree of correlation between the changes observed from in vitro capacitation as a population average and the fertilizing capacity of sperm less clear. To overcome this issue, we used CLARITY tissue clearing to visualize sperm directly inside the female tract in situ and isolated sperm capacitated in vivo from the oviducts of the female mice after timed mating (Ded et al., 2020). Here, we present a step-by-step protocol to collect in vivo capacitated sperm by detailing a microdissection technique and subsequent preparation steps for fluorescent imaging. The advantage of the microdissection technique over in vitro capacitation is the ability to collect physiologically segregated, homogeneous sperm populations at different stages of capacitation. Compared to CLARITY, this technique is more straightforward and compatible with a broader spectrum of antibodies for downstream imaging studies, as it allows the researcher to avoid a potentially high background from non-sperm cells in the tissue. The disadvantage of this technique is the potential contamination of the isolated sperm from different regions of the oviduct and disruption of the fine molecular structures (e.g., CatSper nanodomains) during sperm isolation, especially when the preparation is not performed swiftly. Hence, we suggest that the combination of both in situ and ex vivo isolated sperm imaging is the best way how to address the molecular features of in vivo capacitated sperm., [摘要]哺乳动物的精子细胞在射精后不能立即使卵子受精;相反,它们必须在进入女性生殖道时逐渐获得受精能力。精子细胞在进入输卵管之前通过子宫肌层的肌肉活动运输到子宫 - 输卵管连接处 (UTJ),在那里它们经历称为获能的生理过程。自从哺乳动物体外精子获能的成功模拟导致体外受精技术的发展以来,精子获能和配子相互作用研究大多在体外条件下进行。精子细胞通常在体外培养 以每毫升超过 100 万个细胞的浓度在 37℃含有 5% CO 2 的培养箱,模拟由血清白蛋白、碳酸氢盐和 Ca 2+组成的输卵管液。由此产生的精子在顶体反应、运动和磷酸化方面在功能和分子上是异质的。相比之下,体内精子获能以时间和空间依赖的方式发生,输卵管中获能精子的数量有限。体内受精部位的精子数量少,同质性高,能均匀受精。这种差异使得从体外获能观察到的作为群体平均值的变化与精子受精能力之间的相关程度不太清楚。为了克服这个问题,我们使用 CLARITY 组织清除直接在原位显示雌性管道内的精子,并在定时交配后从雌性小鼠的输卵管中分离出体内获能的精子(Ded等人,2020 年)。在这里,我们提出了一个循序渐进的协议,通过详细介绍显微解剖技术和荧光成像的后续准备步骤来收集体内有能力的精子。显微切割技术优于体外获能的优势在于能够在不同的获能阶段收集生理上分离的、同质的精子群。与 CLARITY 相比,该技术更直接,并且与用于下游成像研究的更广泛的抗体兼容,因为它允许研究人员避免来自组织中非精子细胞的潜在高背景。这种技术的缺点是在精子分离过程中,来自输卵管不同区域的分离精子的潜在污染和精细分子结构(例如,CatSper 纳米域)的破坏,特别是当制备不迅速进行时。因此,我们建议结合原位和离体精子成像是解决体内获能精子分子特征的最佳方法。 [背景]精子获能的发现发生在 1950 年代,当时研究人员未能通过将精子直接添加到卵母细胞而未在接近输卵管液的类似成分的培养基中进行任何事先培养而使卵子在体外受精(Austin,1951;Chang,1951) . 从那时起,绝大多数关于获能的生理和分子过程的现有信息都是使用体外系统获得的,这些系统在 1970 年代首次用于通过体外受精(IVF)受孕(Steptoe 和 Edwards , 1976)。如今,发达国家高达 10% 的儿童是通过辅助生殖技术受孕的,例如体外受精和卵胞浆内单精子注射 (ICSI)。随着这一发展,更需要获得有关自然获能过程的详细知识,并了解其与体外获能的区别。该协议使研究人员能够通过从时间交配的雌性小鼠的生殖道 (UTJ、峡部和壶腹) 的不同位置分离精子来研究精子在获能过程的不同阶段的分子特征。该协议也可用于从小鼠身上回收新鲜射出的精子 (Li et al ., 2015; Chung et al .,...